Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
NCT ID: NCT02454803
Last Updated: 2019-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1004 participants
OBSERVATIONAL
2015-01-31
2019-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
NCT04050527
To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke
NCT01020500
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
NCT01444794
Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A
NCT04340336
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
NCT01239628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has provided written informed consent for collection of the data.
Exclusion Criteria
* Patient has already been included in the current study, but was subsequently withdrawn.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Design Neuroscience
Doral, Florida, United States
Rehabilitation Institute of Chicago
Chicago, Illinois, United States
Kansas City Bone & Joint Clinic
Overland Park, Kansas, United States
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
Vanderbilt University
Nashville, Tennessee, United States
Epworth Rehabilitation Camberwell
Camberwell, , Australia
St Vincent's Hospital
Darlinghurst, , Australia
Austin Health Hospital
Heidelberg, , Australia
Liverpool Brain Injury Rehabilitation Unit
Liverpool, , Australia
Royal Melbourne Hospital
Parkville, , Australia
Prince of Wales Hospital
Randwick, , Australia
RPAH
Sydney, , Australia
Westmead Hospital
Westmead, , Australia
Princess Alexandra Hospital
Woolloongabba, , Australia
Gaitlal-Klinik Hermagor
Hermagor, , Austria
Hospital de Clinicas da UFPR
Curitiba, , Brazil
Fundacao Faculdade Regional de Medicina
São José do Rio Preto, , Brazil
Hospital dos Clinicas Universitaria de Sao Paulo
São Paulo, , Brazil
Centre Régional de Rééducation et Réadaptation Fonctionnelle
Angers, , France
CHU Pellegrin
Bordeaux, , France
Hôpital Raymond Poincaré
Garches, , France
CHU Grenoble Hôpital Sud
Grenoble, , France
Institut Universitaire de Réadaptation de Clémenceau
Strasbourg, , France
Universitaets-Klinikum Erlangen
Erlangen, , Germany
Universitaetsklinikum Leipzig
Leipzig, , Germany
Klinikum rechts der Isar der Technischen Universitaet Muenchen
Munich, , Germany
Schoen Klinik Muenchen Schwabing
Munich, , Germany
Universitaetsklinikum Wuerzburg
Würzburg, , Germany
Tung Wah Hospital
Hong Kong, , Hong Kong
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona
Ancona, , Italy
Azienda Ospedaliero Universitaria Consorziale Policlinico
Bari, , Italy
Ospedale Valduce - Villa Beretta
Costa Masnaga, , Italy
Azienda Ospedaliero Universitaria di Ferrara
Ferrara, , Italy
Azienda Ospedaliero Universitaria Policlinico "G Martino"
Messina, , Italy
Fondazione Santa Lucia, I.R.C.C.S.
Roma, , Italy
Fondazione Don Carlo Gnocchi Onlus
Sarzana, , Italy
Hospital Angeles Clinica Londres
Mexico City, , Mexico
Grupo Torre Medica
México, , Mexico
National Institute of Neurology/Rehabilitation
México, , Mexico
Rehabilitation Centre
Querétaro, , Mexico
Perpetual Succour Hospital
Cebu City, , Philippines
Metropolitan Medical Center
Manila, , Philippines
Academy of Neurology
Krakow, , Poland
Bonacha
Warsaw, , Poland
Public Hospital Wojewodzki
Warsaw, , Poland
Alcoitao Rehabilitation Centre
Alcoitão, , Portugal
Hospital de Faro
Faro, , Portugal
Hospital Egas Moniz
Lisbon, , Portugal
Regional State Budgetary Healthcare Institution "City Hospital N°5"
Barnaul, , Russia
Interregional Cinical and Diagnostic Centre
Kazan', , Russia
Kemerovo Regional Clinical Hospital
Kemerovo, , Russia
Krasnoyarsks State Medical University
Krasnoyarsk, , Russia
Federal State Hospital for Treatment and Rehabilitation
Moscow, , Russia
Federal State Budgetary Institution
Saint Petersburg, , Russia
Pavlov First Saint-Petersburg State Medical University
Saint Petersburg, , Russia
China Medical University Hospital
Taichung, , Taiwan
Veteran General Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):39-48. doi: 10.17116/jnevro202112111139. Russian.
Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S; Upper Limb International Spasticity-III (ULIS-III) study group. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study. J Rehabil Med. 2021 Jan 1;53(1):jrm00133. doi: 10.2340/16501977-2770.
Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III). BMJ Open. 2016 Jun 17;6(6):e011157. doi: 10.1136/bmjopen-2016-011157.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Y-79-52120-206
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.